No Data
No Data
No Data
No Data
No Data
ENTHEON BIOMEDICAL CORP To Carry Out 1-for-10 Reverse Stock Split On March 1st, 2024
February 29th - $ENTHEON BIOMEDICAL CORP(ENTBF.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from March 1st, 2024.$ENTHEO
Futu NewsFeb 29 08:40
RBC Downgrades Nevro to Sector Perform, Cites Salesforce Turnaround
Seeking AlphaJan 13 00:01
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
FinancialNewsMedia.com News Commentary PALM BEACH, Fla., July 27, 2022 /PRNewswire/ -- For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vie
PR NewswireJul 27, 2022 20:51
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider. Numinus (OTC:NUMIF) concluded its acquisition of Novamind (OTC
Benzinga Real-time NewsJun 16, 2022 00:35
Cybin to acquire DMT clinical study from Entheon Biomedical
Cybin (NYSE:CYBN) added ~8% in the pre-market Tuesday after the psychedelics-focused biopharma announced that its subsidiary Cybin IRL Limited agreed to acquire a Phase 1 N,N-dimethyltryptamine ("DMT"
Seeking AlphaJun 7, 2022 20:28
Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research
Ehave, Inc. (OTC:EHVVF) is a leading healthcare services and technology company focused on progressing psychedelics to therapeutics by engineering novel compounds and new treatment protocols for treat
Benzinga Real-time NewsJun 2, 2022 04:35
No Data
No Data